Vertex Pharmaceuticals (VRTX)

Operating Income Growth

8.36%

Quarterly · Period ending:

VRTX logo

VRTX Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported8.36%
VRTX Quarterly Operating Income YoY % (60.00% → 8.36%)
High-resolution chart · PNG

VRTX operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Operating Income Growth — Quarterly
Period endingOperating Income Growth
8.3572%
80.6221%
26.7446%
6.2618%
132.751%
-44.7038%
3.7936%
7.533%
-442.4299%
46.2773%
-4.3541%
-7.8637%
-7.2223%
-25.1609%
17.7509%
6.8456%
3,018.9974%
17.2414%
17.687%
56.8652%
-105.2783%
23.2708%
35.2383%
576.755%
165.9776%
160.189%
331.7698%
-51.6978%
56.1564%
114.7446%
1.5787%
163.0742%
227.9982%
-52.4073%
217.1973%
-1,400.6352%
1,471.9356%
1,990.0349%
171.4402%
68.973%
101.9589%
91.6679%
63.8815%
50.7563%
5.348%
20.5201%
43.9656%
-6.0757%
-217.6277%
50.6288%
-253.867%
-12,417.0868%
-428.6258%
-578.2245%
-134.6026%
-100.4965%
93.5077%
157.3168%
234.3675%
208.0761%
2.1719%
0.239%
-13.5736%
-34.6448%
-7.8935%
0.9951%
-3.423%
-13.4772%
-71.8029%
-63.9655%
-54.6224%
-14.7924%
27.1764%
-11.4037%
-162.6399%
-83.1651%
-58.5671%
-67.998%
-32.352%
-46.2431%
-105.2596%
-24.4245%
34.7265%
-19.3683%
8.6139%
-16.0118%
63.0637%
58.2539%
52.5498%
-290.2947%
-225.199%
-137.7925%
-270.4612%
173.6907%
-116.8513%
0.8353%
-37.7006%
-69.2952%
-7.7981%
-138.2876%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.